CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Purdue Pharma L.P. v. Amneal Pharmaceuticals, LLC

1:11-cv-08153

Overview

Case Number 1:11-cv-08153
Filing Date 2011-11-10
Status Terminated
Termination Date 2014-01-29
Court District Court, S.D. New York (nysd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Amneal Pharmaceuticals, LLC Operating Company

Represented By

5 Attorneys Listed

Counter Defendant

The P.F. Laboratories, Inc. Operating Company

Represented By

3 Attorneys Listed

Rhodes Technologies NPE (Individual / Inventor)

Represented By

3 Attorneys Listed

Grunenthal GMBH NPE (Individual / Inventor)

Represented By

9 Attorneys Listed

Purdue Pharmaceuticals L.P. NPE (University / Research)

Represented By

3 Attorneys Listed

Purdue Pharma L.P. NPE (University / Research)

Represented By

3 Attorneys Listed

Intervenor Defendant

Noramco, Inc. Operating Company

Represented By

5 Attorneys Listed

Court & Judges

Court

District Court, S.D. New York (nysd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 9 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (9): 🇩🇪 Germany 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8309060
Abuse-proofed dosage form
Filed: 2012-01-09
Issued: 2012-11-13
Active (5.1 yrs remaining)
Expires: 2032-01-09
US7674799
Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
Filed: 2007-01-16
Issued: 2010-03-09
Expiring Soon (57 days)
Expires: 2027-01-16
US7647800
Shot, devices, and installations for ultrasonic peening, and parts treated thereby
Filed: 2008-04-24
Issued: 2010-01-19
Active (1.4 yrs remaining)
Expires: 2028-04-24
US7683072
Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
Filed: 2007-01-16
Issued: 2010-03-23
Expiring Soon (57 days)
Expires: 2027-01-16

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

13

Dispositive

3

Granted

2

Denied

0

Pending / Review

11

Motions by Category

Motion for Preliminary Injunction / TRO 3 Procedural / Extension Motion 6 Claim Construction / Markman Filing 4

Key Dispositive Motions & Rulings

Motion for Preliminary Injunction / TRO Pending / Under Review
ORDER FOR ADMISSION OF BASIL J. LEWRIS, ESQ. PRO HAC VICE ON WRITTEN MOTION granting 10 Motion for Basil J. Lewris to Appear Pro Hac Vice. (Signed by Judge Sidn...
Entry #11 • 2011-12-21 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
ORDER FOR ADMISSION OF JENNIFER H. ROSCETTI, ESQ. PRO HAC VICE ON WRITTEN MOTION granting 9 Motion for Jennifer H. Roscetti to Appear Pro Hac Vice. (Signed by J...
Entry #12 • 2011-12-21 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
ORDER FOR ADMISSION OF JOANN M. NETH, ESQ. PRO HAC VICE ON WRITTEN MOTION granting 6 Motion for Joann M. Neth to Appear Pro Hac Vice. (Signed by Judge Sidney H....
Entry #13 • 2011-12-21 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM CONSTRUCTION OPINION AND ORDER. These patents, as further specified in this Claim Construction Opinion and Order, will now proceed to trial. On the basis ...
Entry #81 • 2013-08-23 Document →
Claim Construction / Markman Filing Pending / Under Review
JOINDER to join Defendants' Claim Construction Briefing. Document filed by Amneal Pharmaceuticals, LLC.(Sender, Stuart) (Entered: 06/17/2013)
Entry #80 • 2013-06-17 Document →
Claim Construction / Markman Filing Pending / Under Review
ORDER: On July 15, 2013, at 9:30 a.m., the Court will hold a Markman hearing to construe the claims at issue in the patents listed herein. The Markman hearing w...
Entry #78 • 2013-05-08 Document →

Docket Entries

(106 total)
Pleading / Complaint

COMPLAINT against Amneal Pharmaceuticals, LLC. (Filing Fee $ 350.00, Receipt Number 465401021635)Document filed by Purdue Pharma L.P., The P.F. Laboratories, Inc., Rhodes Technologies, Grunenthal GMBH, Purdue Pharmaceuticals L.P.(mro) (Additional attachment(s) added on 12/8/2011: # 1 Exhibit, # 2 Exhibit) (rdz). (Entered: 11/14/2011)

Entry #1 • 2011-11-10
1
Pleading / Complaint

COMPLAINT against Amneal Pharmaceuticals, LLC. (Filing Fee $ 350.00, Receipt Number 465401021635)Document filed by Purdue Pharma L.P., The P.F. Laboratories, Inc., Rhodes Technologies, Grunenthal GMBH, Purdue Pharmaceuticals L.P.(mro) (Additional attachment(s) added on 12/8/2011: # 1 Exhibit, # 2 Exhibit) (rdz). (Entered: 11/14/2011)

Entry #1 • 2011-11-10
2
Pleading / Complaint

COMPLAINT against Amneal Pharmaceuticals, LLC. (Filing Fee $ 350.00, Receipt Number 465401021635)Document filed by Purdue Pharma L.P., The P.F. Laboratories, Inc., Rhodes Technologies, Grunenthal GMBH, Purdue Pharmaceuticals L.P.(mro) (Additional attachment(s) added on 12/8/2011: # 1 Exhibit, # 2 Exhibit) (rdz). (Entered: 11/14/2011)

Entry #1 • 2011-11-10
2

STATEMENT OF RELATEDNESS PURSUANT TO LOCAL RULE 1.6 re: that this action be filed as related to 11-cv-2036. Document filed by Grunenthal GMBH, Purdue Pharma L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies, The P.F. Laboratories, Inc.(mro) (Entered: 11/14/2011)

Entry #2 • 2011-11-10
1

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Grunenthal GMBH.(mro) (Entered: 11/14/2011)

Entry #3 • 2011-11-10
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc